CA-78378/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1998	1
2001	4
2002	2
2003	3
2005	4
2006	1
2007	1
2008	2
2025	0

1

Novel therapies targeting the myeloma cell and its bone marrow microenvironment.

Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC. Hideshima T, et al. Semin Oncol. 2001 Dec;28(6):607-12. doi: 10.1016/s0093-7754(01)90033-8. Semin Oncol. 2001. PMID: 11740818 Review.

2

Proteasome inhibition as a novel therapeutic target in human cancer.

Rajkumar SV, Richardson PG, Hideshima T, Anderson KC. Rajkumar SV, et al. J Clin Oncol. 2005 Jan 20;23(3):630-9. doi: 10.1200/JCO.2005.11.030. J Clin Oncol. 2005. PMID: 15659509 Review.

3

Viral antigen-specific CD8+ T-cell responses are impaired in multiple myeloma.

Maecker B, Anderson KS, von Bergwelt-Baildon MS, Weller E, Vonderheide RH, Richardson PG, Schlossman RL, Menezes IA, Xia Z, Munshi NC, Anderson KC, Nadler LM, Schultze JL. Maecker B, et al. Br J Haematol. 2003 Jun;121(6):842-8. doi: 10.1046/j.1365-2141.2003.04375.x. Br J Haematol. 2003. PMID: 12786794 Free article.

4

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants.

von Bergwelt-Baildon M, Shimabukuro-Vornhagen A, Popov A, Klein-Gonzalez N, Fiore F, Debey S, Draube A, Maecker B, Menezes I, Nadler LM, Schultze JL. von Bergwelt-Baildon M, et al. Blood. 2006 Apr 1;107(7):2786-9. doi: 10.1182/blood-2004-01-0113. Epub 2005 Dec 15. Blood. 2006. PMID: 16357329 Free PMC article.

5

A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.

Podar K, Gouill SL, Zhang J, Opferman JT, Zorn E, Tai YT, Hideshima T, Amiot M, Chauhan D, Harousseau JL, Anderson KC. Podar K, et al. Oncogene. 2008 Jan 31;27(6):721-31. doi: 10.1038/sj.onc.1210679. Epub 2007 Jul 23. Oncogene. 2008. PMID: 17653083

6

Adenovirus vector-based purging of multiple myeloma cells.

Teoh G, Chen L, Urashima M, Tai YT, Celi LA, Chen D, Chauhan D, Ogata A, Finberg RW, Webb IJ, Kufe DW, Anderson KC. Teoh G, et al. Blood. 1998 Dec 15;92(12):4591-601. Blood. 1998. PMID: 9845525 Free article.

7

Allotransplantation for multiple myeloma.

Alyea EP, Anderson KC. Alyea EP, et al. Cancer J. 2001 May-Jun;7(3):166-74. Cancer J. 2001. PMID: 11419023 Review. No abstract available.

8

Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.

Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC. Treon SP, et al. J Immunother. 2001 May-Jun;24(3):263-71. J Immunother. 2001. PMID: 11394505

9

Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM, Schultze JL, von Bergwelt-Baildon MS. Kondo E, et al. Clin Cancer Res. 2008 Oct 15;14(20):6574-9. doi: 10.1158/1078-0432.CCR-08-0825. Clin Cancer Res. 2008. PMID: 18927298

10

Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12.

Gong J, Koido S, Chen D, Tanaka Y, Huang L, Avigan D, Anderson K, Ohno T, Kufe D. Gong J, et al. Blood. 2002 Apr 1;99(7):2512-7. doi: 10.1182/blood.v99.7.2512. Blood. 2002. PMID: 11895787 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year